Assignee
UNIV KAGOSHIMA
JP·35 granted patents·36 pending applications·35 citations·filing 1989–2024
Top patents by PatentIndex Score
71 records- 0194US10227383B2Specific modification of antibody with IgG-binding peptideUNIV KAGOSHIMA·Filed 2016·Granted Mar 12, 2019·7 cites·20 claims
- 0278US8372950B2IgG binding peptideUNIV KAGOSHIMA·Filed 2007·Granted Feb 12, 2013·5 cites·13 claims
- 0376US9522196B2Antibody recognizing folate receptors α and βUNIV KAGOSHIMA·Filed 2013·Granted Dec 20, 2016·7 cites·15 claims
- 0476US2024368223A1SITE-SPECIFIC RADIOISOTOPE-LABELED ANTIBODY USING IgG-BINDING PEPTIDEUNIV KAGOSHIMA·Filed 2024·Application pending·0 cites
- 0575US12037417B2Site-specific radioisotope-labeled antibody using IgG-binding peptideUNIV KAGOSHIMA·Filed 2017·Granted Jul 16, 2024·1 cites·7 claims
- 0674US11432742B2Airway ventilation state calibration system and system for predicting airway deformation during sleepUNIV KAGOSHIMA·Filed 2018·Granted Sep 6, 2022·2 cites·10 claims
- 0773US11186613B2Solid-phase support comprising IgG-binding peptide, and method for separating IgGUNIV KAGOSHIMA·Filed 2017·Granted Nov 30, 2021·1 cites·19 claims
- 0871US12503575B2Fine hollow particles comprising melamine-based resinUNIV KAGOSHIMA·Filed 2022·Granted Dec 23, 2025·0 cites·8 claims
- 0970US11583463B2Hemiplegic forearm function recovery training device and methodUNIV KAGOSHIMA·Filed 2018·Granted Feb 21, 2023·1 cites·9 claims
- 1070US11365194B2Analgesic drug using PAC1 receptor antagonistic drugUNIV KAGOSHIMA·Filed 2018·Granted Jun 21, 2022·1 cites·3 claims
- 1169US11110414B2Bubble generation device, tubular member, bubble generation method, and method for manufacturing bubble generation deviceUNIV KAGOSHIMA·Filed 2017·Granted Sep 7, 2021·1 cites·16 claims
- 1266US11001557B2Antiviral drug for severe fever with thrombocytopenia syndromeUNIV KAGOSHIMA·Filed 2018·Granted May 11, 2021·1 cites·9 claims
- 1363US10662441B2Viral vector targeting cancer stem cellsUNIV KAGOSHIMA·Filed 2018·Granted May 26, 2020·0 cites·16 claims
- 1463US2025161529A1Method for preparing medical hydrogel and medical hydrogelUNIV KAGOSHIMA·Filed 2023·Application pending·0 cites
- 1562US2024191036A1Polysiloxane composition, adhesive, method for producing polysiloxane composition, and method for producing adhesiveUNIV KAGOSHIMA·Filed 2022·Application pending·0 cites
- 1661US2024148807A1Oncolytic virus (oncolytic immunotherapy) capable of effectively treating even metastatic cancer while ensuring safety, with expression control system providing optimal expression level of mounted immunogenic geneUNIV KAGOSHIMA·Filed 2024·Application pending·0 cites
- 1760US2025059509A1Method for producing macrophages, differentiation inducing agent, differentiation induction kit, method for culturing macrophages, agent for promoting macrophage propagation, kit for promoting macrophage proliferation, method for macrophage proliferation, and macrophagesUNIV KAGOSHIMA·Filed 2022·Application pending·0 cites
- 1859USRE50282ESpecific modification of antibody with IgG-binding peptideUNIV KAGOSHIMA·Filed 2016·Granted Jan 28, 2025·0 cites·41 claims
- 1959US2024391950A1Peptide crosslinking agent and crosslinked peptide which is crosslinked using said crosslinking agentUNIV KAGOSHIMA·Filed 2021·Application pending·0 cites
- 2057US2025325547A1Anti-sars-cov-2 drugUNIV KAGOSHIMA·Filed 2022·Application pending·0 cites
- 2157US2013295689A1Method for detection of basic peptide and reagent for detection of basic peptideUNIV KAGOSHIMA·Filed 2013·Application pending·0 cites
- 2256US10772887B2Anti-HTLV-1 drug and therapeutic agent for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)UNIV KAGOSHIMA·Filed 2017·Granted Sep 15, 2020·0 cites·2 claims
- 2355US11896635B2Oncolytic virus (oncolytic immunotherapy) capable of effectively treating even metastatic cancer while ensuring safety, with expression control system providing optimal expression level of mounted immunogenic geneUNIV KAGOSHIMA·Filed 2018·Granted Feb 13, 2024·0 cites·7 claims
- 2455US11198106B2Method for producing microcapsules or beadsUNIV KAGOSHIMA·Filed 2018·Granted Dec 14, 2021·0 cites·3 claims
- 2555US2026084120A1Bubble generation device, bubble generation method, and method of producing bubble generating memberUNIV KAGOSHIMA·Filed 2023·Application pending·0 cites
- 2655US2015167186A1Electrochemical reactor and method for producing fuel gasUNIV KAGOSHIMA·Filed 2013·Application pending·0 cites
- 2755US2025387763A1Air bubble forming device, air bubble forming method, evaluation device, and evaluation methodUNIV KAGOSHIMA·Filed 2023·Application pending·0 cites
- 2854US2010256379A1Anti-viral agent containing heterocyclic aromatic compound as active ingredientUNIV KAGOSHIMA·Filed 2008·Application pending·0 cites
- 2953US12400018B2Data distribution system, data distribution device, recording medium, and data distribution methodUNIV KAGOSHIMA·Filed 2023·Granted Aug 26, 2025·0 cites·14 claims
- 3052US2021138037A1Novel application of heparin-binding epidermal growth factor-like growth factor for medical purposesUNIV KAGOSHIMA·Filed 2020·Application pending·0 cites
- 3151US12458643B2Antidepressant/anxiolytic drug in which PAC1 receptor antagonist is usedUNIV KAGOSHIMA·Filed 2021·Granted Nov 4, 2025·0 cites·14 claims
- 3251US2011117602A1Human antibody capable of inducing apoptosisUNIV KAGOSHIMA·Filed 2008·Application pending·0 cites
- 3351US2022363716A1Method for producing monovalent ccap productUNIV KAGOSHIMA·Filed 2020·Application pending·0 cites
- 3450US2016000782A1Pharmaceutical composition containing antibacterial agentUNIV KAGOSHIMA·Filed 2014·Application pending·0 cites
- 3550US2024359152A1Capsule production method and capsule production deviceUNIV KAGOSHIMA·Filed 2022·Application pending·0 cites
- 3650US2009054596A1Composite Particulate and Manufacturing Method for the SameUNIV KAGOSHIMA·Filed 2005·Application pending·0 cites
- 3749US12202858B2Solid-phase carrier including IgG-binding peptide, and IgG separation methodUNIV KAGOSHIMA·Filed 2019·Granted Jan 21, 2025·0 cites·20 claims
- 3849US11472865B2IgG-binding peptide, and specific modification of antibody with said peptideUNIV KAGOSHIMA·Filed 2018·Granted Oct 18, 2022·0 cites·18 claims
- 3948US2025304617A1Compound, salt of compound, antibody modification reagent, method for producing modified antibody, and modified antibodyUNIV KAGOSHIMA·Filed 2022·Application pending·0 cites
- 4046US11643474B2Peptide fusion proteinUNIV KAGOSHIMA·Filed 2019·Granted May 9, 2023·0 cites·12 claims
- 4146US2011077204A1Agent for Targeted Drug Delivery To Cerebral NeuronsUNIV KAGOSHIMA·Filed 2007·Application pending·0 cites
- 4246US2014248655A1Quantitative soft agar colony formation assay using tetrazolium that generates water-soluble formazanUNIV KAGOSHIMA·Filed 2012·Application pending·0 cites
- 4344US2019024181A1Method for detecting oral precancerous lesionUNIV KAGOSHIMA·Filed 2016·Application pending·0 cites
- 4444US2023414718A1Low-dose hepatocyte growth factor gene therapy for diabetesUNIV KAGOSHIMA·Filed 2021·Application pending·0 cites
- 4544US2024173381A1Hb-egf gene therapy for diabetesUNIV KAGOSHIMA·Filed 2022·Application pending·0 cites
- 4643US12583564B2Seafarer safety device, seafarer safety system, seafarer safety program, vessel activity inference device, report generation assistance system, and vessel activity inference programUNIV KAGOSHIMA·Filed 2023·Granted Mar 24, 2026·0 cites·14 claims
- 4743US10987372B2Anti-hepatoma-virus agentUNIV KAGOSHIMA·Filed 2017·Granted Apr 27, 2021·0 cites·10 claims
- 4843US2015044701A1IgA-BINDING PEPTIDE AND IgA PURIFICATION USING THE SAMEUNIV KAGOSHIMA·Filed 2012·Application pending·0 cites
- 4943US2022184081A1Antipruritic agent using pac1 receptor antagonistUNIV KAGOSHIMA·Filed 2020·Application pending·0 cites
- 5043US2015313659A1Fastening force auxiliary device for screw and screw with fastening force auxiliary deviceUNIV KAGOSHIMA·Filed 2013·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →